Sopharma Trading to expand its business in Serbia – Bulgarian pharmaceutical company planning new investments

Sopharma Trading, the biggest Bulgarian company by revenues realized in the pharmaceutical sector, is ready to expand its operations in the Serbian market and become a strategic investor in the region. The Executive Director of Sopharma Trading Group, Dimitar Dimitrov, and the Executive Director of the company in Serbia, Milos Ristic, discussed the plans for further development on Thursday, June 21, 2018.

As an innovator in key segments of the pharmaceutical market - wholesale, retail, medical equipment, Sopharma Trading is planning to implement its successful and varied business model in Serbia and the whole region.

As part of the planned realization of a continued dynamic growth, the company initiated a regional expansion three years ago by opening the first operating unit in Belgrade, focusing on exclusive brands meant for preservation of health and beauty.

In 2017, Sopharma Trading became the majority owner of Lekovit.

– The first step is for us to become leaders in Serbia with a considerable expansion of operations and logistics potential. We will use this development model as a basis for regional expansion, because Sopharma Trading is looking at the entire region of East Europe, especially the Balkans, as a remarkable opportunity for growth – Dimitrov said.

He pointed out that the company would implement the best world practices, modern technologies and innovations.

Sopharma Trading Pharmaceuticals d.o.o. Beograd

Sopharma Trading

Lekovit

Dimitar Dimitrov

Milos Ristic

wholesale pharmacies

investments in the pharmaceutical sector